TLCR Reading Tools
How to cite item
Efficacy and safety of finotonlimab plus docetaxel
vs
. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{98990}, author = {Han, B., Wu, L., Yang, R., Wu, H., Li, W., Yu, Y., Zhang, M., Sun, H., Chu, T., Zhong, F., Fang, Y., Wu, R., Bian, T., Guo, X., Sun, M., Zhang, Y., Liu, L., Liu, X., Pan, Y., Jiang, O., Wei, Z., Lin, H., Guo, W., Fang, J., Wang, J., Ding, C., Hu, Y., Ye, F., Zhuang, W., Ye, S., Wang, L., Huang, Z., Liu, C., Yang, L., Wang, J., Xie, L.}, title = {Efficacy and safety of finotonlimab plus docetaxel <em>vs</em>. docetaxel in previously treated advanced squamous cell non-small-cell lung cancer: a randomized, double-blinded, phase III trial}, journal = {Translational Lung Cancer Research}, volume = {0}, number = {0}, year = {2025}, url = {https://tlcr.amegroups.org/article/view/98990} }